Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
3.060
-0.010 (-0.33%)
Apr 6, 2026, 4:00 PM EDT - Market closed
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $7.11 million as of April 6, 2026. Its market cap has decreased by -55.50% in one year.
Market Cap
7.11M
Enterprise Value
-1.47M
1-Year Change
-55.50%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $7.11M, a decrease of -61.54%. That is a compound annual growth rate of -5.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 6.96M | -71.77% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Creative Medical Technology Holdings | 7.91M |
| PharmaCyte Biotech | 7.59M |
| Processa Pharmaceuticals | 7.45M |
| PMGC Holdings | 7.44M |
| GridAI Technologies | 7.33M |
| Xenetic Biosciences | 7.23M |
| Aptorum Group | 7.21M |
| NuCana | 6.99M |